Amphista Therapeutics is a UK-based biotech company focused on targeted protein degradation to develop new treatments for diseases
Amphista Therapeutics is a UK-based biotech company focused on targeted protein degradation to develop new treatments for diseases. The company aims to create first-class therapeutics that selectively degrade and remove disease-causing proteins by harnessing the body’s natural processes.